Stockscreener 앱 받기
1.29
2.38%
0.03
전일 마감가:
$1.26
열려 있는:
$1.27
하루 거래량:
12,664
Relative Volume:
0.13
시가총액:
$37.20M
수익:
$48.20M
순이익/손실:
$-35.05M
주가수익비율:
-0.8231
EPS:
-1.5673
순현금흐름:
$-13.02M
1주 성능:
+6.61%
1개월 성능:
-28.73%
6개월 성능:
-39.15%
1년 성능:
-40.55%
1일 변동 폭
$1.25
$1.31
1주일 범위
$1.20
$1.31
52주 변동 폭
$1.01
$4.35
Celularity Inc Stock (CELU) Company Profile
명칭
Celularity Inc
전화
(908) 768-2170
주소
170 PARK AVE, FLORHAM PARK
CELU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.29 | 36.34M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.29 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
800.48 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.39 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
802.31 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
339.38 | 35.45B | 4.98B | 69.59M | 525.67M | 0.5197 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-30 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-06-22 | 개시 | H.C. Wainwright | Buy |
| 2022-04-06 | 다운그레이드 | Truist | Buy → Hold |
| 2022-01-28 | 개시 | Oppenheimer | Outperform |
| 2021-11-24 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Celularity Inc 주식(CELU)의 최신 뉴스
Why Celularity Inc. Equity Warrant stock could see breakout soonJuly 2025 Intraday Action & Technical Confirmation Trade Alerts - ulpravda.ru
Will Celularity Inc. stock split attract more investors2025 Trading Volume Trends & Stock Portfolio Risk Management - ulpravda.ru
Is Celularity Inc. Equity Warrant stock a smart buy before Fed meetingInflation Watch & Proven Capital Preservation Tips - ulpravda.ru
Will Celularity Inc. stock outperform tech sector in 2025Stock Price Divergence & Fast Growing Trading Plans - ulpravda.ru
Does Shoora Designs Limited Stock Fit a LongTerm Value StrategyMarket Rumors and News & High Return Stock Ideas - earlytimes.in
Sheppard Mullin Advised Vanterra Ventures, Silo Pharma, Celularity And Others In Recent Deals - Mondaq
Celularity files for offering of up to 14.1 million shares of class A common stock - MarketScreener
Celularity Files for Sale of 14.1 Million Class A Shares - marketscreener.com
Celularity (NASDAQ:CELU) Trading Down 10.4% – Here’s Why - Defense World
Celularity's Biovance, Biovance 3L To Remain Eligible For Med. Coverage Under Withdrawn LCDs - Nasdaq
Aug Outlook: What Wall Street predicts for Celularity Inc Equity Warrant stock price2025 Breakouts & Breakdowns & Consistent Return Strategy Ideas - moha.gov.vn
Celularity secures new financing to support strategic shift - MSN
Celularity CEO Comments on Centers for Medicare & Medicaid Services' Withdrawal of Skin Substitute Local Coverage Determinations - Investing News Network
Celularity stock drops after CMS withdraws skin substitute LCDs By Investing.com - Investing.com Nigeria
Celularity stock drops after CMS withdraws skin substitute LCDs - Investing.com
Celularity Inc. Comments on CMS Withdrawal of Skin Substitute Coverage Determinations - Quiver Quantitative
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations - The Manila Times
Medicare rewrites rules for wound skin grafts; Celularity says it’s ready - Stock Titan
Celularity Secures New Financing To Support Strategic Shift - The Globe and Mail
Celularity Signs Multiple Material Agreements - TradingView — Track All Markets
Celularity Announces Closing of Financing Transactions - The Manila Times
Celularity Closes Financing Transactions - citybiz
Celularity secures $10 million financing from DoubleLine co-founder By Investing.com - Investing.com Nigeria
Celularity secures $10 million financing from DoubleLine co-founder - Investing.com India
Longevity-focused biotech Celularity raises $10M for aging research - Stock Titan
Celularity announces up to $12M of capital from Philip Barach - MSN
Why Celularity Inc. Equity Warrant stock could rally in 20252025 Price Action Summary & Verified Swing Trading Watchlist - DonanımHaber
Celularity Shareholders Reject Expansion of Equity Incentive Plan - The Globe and Mail
Can Celularity Inc. stock deliver surprise earnings beatJuly 2025 Earnings & AI Enhanced Trading Alerts - Улправда
Why Celularity Inc. Equity Warrant stock could benefit from AI revolution2025 Stock Rankings & Safe Investment Capital Preservation Plans - Улправда
Celularity raises $12m to sharpen longevity strategy - Longevity.Technology
What Wall Street predicts for Celularity Inc. Equity Warrant stock priceAnalyst Downgrade & Real-Time Sentiment Analysis - DonanımHaber
Is Celularity Inc. Equity Warrant stock dividend yield sustainable2025 Market Outlook & AI Based Buy and Sell Signals - DonanımHaber
Why Celularity Inc. stock is favored by top institutionsStop Loss & Weekly Watchlist for Hot Stocks - DonanımHaber
Will Celularity Inc. Equity Warrant stock outperform Dow Jones indexPortfolio Risk Report & Risk Controlled Swing Alerts - DonanımHaber
Performance Recap: Will Celularity Inc. stock outperform tech sector in 2025Weekly Trade Summary & Growth Focused Stock Reports - moha.gov.vn
Why Celularity Inc. stock is favored by pension funds2025 Risk Factors & Precise Buy Zone Identification - Улправда
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision - Investing News Network
Celularity secures up to $12 million in financing for longevity focus - Investing.com Australia
Celularity Inc. Secures Up to $12 Million in Financing to Advance Strategic Priorities in Longevity and Human Performance - Quiver Quantitative
DoubleLine co-founder backs up to $12M funding plan for longevity - Stock Titan
Celularity Inc.'s (NASDAQ:CELU) 25% Dip In Price Shows Sentiment Is Matching Revenues - 富途牛牛
Celularity Inc. announced that it expects to receive $12 million in funding - marketscreener.com
There Is A Reason Celularity Inc.'s (NASDAQ:CELU) Price Is Undemanding - simplywall.st
Celularity Inc (CELU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Celularity Inc 주식 (CELU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
0.37%
자본화:
|
볼륨(24시간):